← All trials
NCT04455815
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 25, 2020
- Primary completion
- Aug 31, 2021
- Completion date
- Aug 31, 2021
- First posted
- Jul 2, 2020
- Last posted
- Dec 7, 2020
- Enrollment
- 389
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Cancer Research UKLead sponsor
- Latus TherapeuticsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.